Impact of Non-invasive Brain Stimulation on Learning Novel Spoken Words

Status Recruiting

Clinical Trial Summary

The purpose of the proposed study is to use transcranial magnetic stimulation (TMS) to evaluate a neurobiological model of spoken word learning in older youth. Specifically, it is hypothesized that: (1) inhibition of the left dorsal stream will impact subsequent learning, processing, and retention of phonologically similar pseudowords; (2) the impact of dorsal stream inhibition on word learning will be associated with baseline levels of variability in neural activity, indicative of underlying differences in cortical excitability.

Clinical Trial Description

The proposed study is designed to assess the contribution of the dorsal stream of the language network (i.e., left supramarginal gyrus, or SMG) to different aspects of novel word learning in two groups of participants (16-24 years of age): 20 typically developing older youth (OYTD; tested in Aim 1) and 20 older youth with reading difficulties (OYRD; tested in Aim 2). The investigators will use inhibitory continuous theta burst stimulation (cTBS), a well-established repetitive TMS (rTMS) protocol that reduces cortical excitability in a targeted brain region for up to 60 minutes. Participants will complete a baseline magnetic resonance imaging (MRI) session in Week 1, followed by cTBS or sham stimulation to the left SMG, with order of administration counterbalanced across participants. Immediately following cTBS (or sham), participants will complete a visual pseudoword phonological discrimination task and a spoken word learning task. The following day (i.e., 24 hours later), retention of items learned will be measured. In Week 2, cTBS (or sham) will be administered to the left SMG (whichever stimulation was not administered in Week 1) and then the pseudoword discrimination and word learning tasks will be administered using a different set of novel words from those presented in Week 1. Twenty-four hours later, the retention of this second set of items will be measured. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06387615
Study type	Interventional
Source	Georgia State University
Contact	C.Nikki Arrington, PhD
Phone	404-385-8621
Email	carrington3@gsu.edu
Status	Recruiting
Phase	N/A
Start date	January 1, 2024
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00716274` - Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia	Phase 4
Recruiting	`NCT03695068` - Efficacy of a Two-Year Intensive Reading Intervention for Middle School English Learners With Reading Difficulties	N/A
Completed	`NCT04277351` - Role of Auditory Cortical Oscillations in Speech Processing and Dyslexia	N/A
Recruiting	`NCT05996497` - Evaluation of Speech Rhythm Training in Dyslexic Readers Aged 7 to 9 Years	N/A
Not yet recruiting	`NCT04989088` - Neurofeedback Training for Dyslexia	N/A
Completed	`NCT02429739` - Working Memory Training for Children With Dyslexia	N/A
Completed	`NCT05154721` - Rhythm Training of a Serious Game on the Reading Skills of Children w/ a Specific Learning Disorder Impacting Reading	N/A
Completed	`NCT01930500` - The Effectiveness of Neuropsychological Rehabilitation in Young Dyslexic Adults	N/A
Unknown status	`NCT00818428` - Randomized Clinical Trial of Phonological Interventions	Phase 2/Phase 3
Recruiting	`NCT05514457` - Assessment of Visual Dyslexia Remediation Protocols - Dyslexia REMEDIATION	N/A
Completed	`NCT04642859` - Training Second-grade Dyslexic Students Using a Computerized Program in Assiut, Egypt	N/A
Completed	`NCT01012778` - Implementation of Climb Up Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) and Dyslexia in a School in India	Phase 1/Phase 2
Not yet recruiting	`NCT06127550` - taVNS for Letter Learning in Dyslexia	N/A
Completed	`NCT04244578` - Transcranial Direct Current Stimulation in the Treatment of Dyslexia.	N/A
Recruiting	`NCT05636813` - Usefulness of an Assistive Technology Training Program for Adolscents With Dyslexia	N/A
Completed	`NCT02872870` - Developmental Language Difficulties: Behavioural and Electrophysiological Studies	N/A
Completed	`NCT00607919` - Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia	Phase 4
Completed	`NCT00245804` - Developmental Dyslexia and Functional Maturation of Auditory Cortex	N/A
Completed	`NCT02345876` - Maturation of Auditory Processing in Children With Dyslexia Compared to Average-reading Children
Completed	`NCT04708899` - Development of an Arabic Central Auditory Processing Remediation Program for Dyslexic Children With(C)APD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.